Skip to main navigation Skip to search Skip to main content

Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer

  • Nadiya Druzhyna
  • , Bartosz Szczesny
  • , Gabor Olah
  • , Katalin Módis
  • , Antonia Asimakopoulou
  • , Athanasia Pavlidou
  • , Petra Szoleczky
  • , Domokos Gerö
  • , Kazunori Yanagi
  • , Gabor Törö
  • , Isabel López-García
  • , Vassilios Myrianthopoulos
  • , Emmanuel Mikros
  • , John R. Zatarain
  • , Celia Chao
  • , Andreas Papapetropoulos
  • , Mark R. Hellmich
  • , Csaba Szabo

Research output: Contribution to journal › Article › peer-review

73   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science